PANSS: Positive and Negative Syndrome Scale

What this assessment is

The Positive and Negative Syndrome Scale, or PANSS, is a 30-item clinician-rated assessment of symptoms associated with schizophrenia.

It produces three primary scale scores:

• Positive Scale
• Negative Scale
• General Psychopathology Scale

The three scales combine to form a total from 30 to 210, but the separate profiles remain necessary for clinical interpretation.

Totals lose detail.

Each rating begins at 1 rather than 0. This means a completed total cannot be below 30.

Floors matter.

PANSS describes symptom severity. It does not diagnose schizophrenia or establish the cause of a symptom.

This page covers the standard 30-item model, not PANSS-6, PANSS-8, or another short form.

Who it was designed for

Kay, Fiszbein, and Opler introduced PANSS in 1987 for adults with schizophrenia. The original publication describes the positive, negative, and general psychopathology model.

The scale is used in specialist care and research, where a trained clinician combines interview findings, observed behavior, and relevant collateral information.

Training is essential.

The official PANSS record identifies a semi-structured interview, an informant guide, rating criteria, and training materials.

Training matters.

PANSS is not designed as a self-report questionnaire. Some ratings require direct observation and information from people who know the patient's recent functioning, not only answers from one interview.

Use the exact PANSS model and language named in the record. Short forms and factor models answer different questions.

How it is administered

A trained clinician conducts a semi-structured interview and reviews behavior and collateral information.

Administration commonly takes 30 to 40 minutes, although the full process can take longer when symptoms are complex or information is limited.

Each rating must use its standard definition, severity criteria, and evidence basis so that different clinicians apply the same numerical scale.

Consistency needs work.

Before the assessment, define:

• the version and model
• the timeframe
• the information sources
• the rater and training standard
• whether the assessment is a baseline or follow-up

Keep these points stable during repeat measurement.

Do not rate a symptom as absent only because the interview did not reveal it. Some ratings need collateral evidence or observation over time.

Document insufficient information rather than guessing.

What it measures

The Positive Scale covers symptoms added to ordinary mental experience, such as unusual beliefs, perceptual experiences, and disorganized thinking.

The Negative Scale covers reductions in expression, motivation, social engagement, and spontaneous communication.

The General Psychopathology Scale covers a wider set of emotional, cognitive, behavioral, and physical features.

These groups are clinical constructs. They are not complete descriptions of the person or their functioning.

The BPRS provides a shorter broad psychiatric symptom rating. PANSS gives a more detailed schizophrenia-focused profile with separate positive and negative scales.

The AIMS assesses involuntary movements. It can provide different information when treatment monitoring includes movement effects.

Do not mix symptom and movement totals.

How scoring works

Each PANSS item is rated from 1 to 7. Higher values indicate greater severity.

The primary ranges are:

• Positive Scale: 7 to 49
• Negative Scale: 7 to 49
• General Psychopathology Scale: 16 to 112
• Total: 30 to 210

The total is the sum of all 30 ratings, each of which contributes at least one point even when the rated symptom is absent.

A positive-minus-negative composite can also be calculated. Its range is minus 42 to 42. This is a derived index, not a substitute for the primary scales.

Because every item begins at 1, research sometimes subtracts 30 from the total before calculating percentage change. That transformation produces a 0-based value.

Label it clearly.

Do not compare a transformed total with an untransformed total. Do not infer a missing-item rule when the protocol does not provide one.

How to interpret a PANSS score

Higher scores indicate greater clinician-rated symptom severity within the same version and rating method.

Interpret the three scale scores before relying on the total. A stable total can hide improvement in one area and worsening in another.

There are no universal PANSS total bands that diagnose mild, moderate, or severe schizophrenia in every setting.

Do not create them.

For follow-up, compare results only when the model, timeframe, training, information sources, and scoring transformation remain the same.

Percentage change also needs care. A percentage calculated from a raw 30-to-210 total is different from one calculated after subtracting the 30-point floor.

State the formula.

A multisite methods study confirms the 7-item positive, 7-item negative, and 16-item general structure and emphasizes trained clinical rating.

Explain any score change with the underlying clinical findings.

What the score cannot tell you

PANSS cannot diagnose schizophrenia or distinguish it from mood, substance-related, neurological, or medical conditions by itself.

It cannot establish why symptoms changed. Treatment, environment, sleep, substance use, acute illness, and rater differences can all affect the result.

The total cannot show daily function, quality of life, treatment preference, capacity, or movement effects in enough detail.

A lower score does not prove recovery. A higher score does not identify the treatment needed.

PANSS also does not replace a direct safety assessment.

Do not make a major care decision from the total alone.

Use the interview, scale profile, history, physical assessment, function, and the person's own account.

Evidence and limitations

PANSS provides a structured and widely studied symptom profile. Its three primary scales support more detail than one global total.

The assessment is demanding. Reliable use depends on training, interview skill, collateral information, and consistent application of the rating criteria.

Interrater variation can be clinically important. Language, culture, insight, communication differences, and the availability of informants can also affect ratings.

Different PANSS models and short forms are not interchangeable. Factor scores derived in one sample may not reproduce in another.

The total compresses clinically different symptoms into one number.

Profiles differ.

A stored total without its three primary scale scores can hide a clinically important shift between positive, negative, and general symptoms.

Report the version, model, timeframe, rater, three primary scale scores, total, and any transformation used.

Keep the clinical profile visible.